← Back to Search

Antimicrobial Agent

Next Science for Surgical Site Infection

N/A
Waitlist Available
Led By Robert Harris, MD
Research Sponsored by Next Science TM
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new treatment for tibial fractures to see if it is safe and effective.

Eligible Conditions
  • Surgical Site Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Surgical Site Infection
Secondary study objectives
Deep Bioburden
Superficial Bioburden

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care plus Next ScienceExperimental Treatment1 Intervention
In addition to the SoC, the blinded product will be applied in place of saline irrigation as the wound is closed (after bone fracture preparation/fixation), depending on the randomization.
Group II: Standard of CareActive Control1 Intervention
Each of the following procedures will be conducted according to general or local site Standard of Care (SoC): * Medication administration at surgery * Surgical irrigation and wound debridement * Surgical fracture preparation/fixation * Surgical closure

Find a Location

Who is running the clinical trial?

Hughston ClinicOTHER
1 Previous Clinical Trials
130 Total Patients Enrolled
IACT HealthUNKNOWN
Next Science TMLead Sponsor
15 Previous Clinical Trials
9,507 Total Patients Enrolled

Media Library

Next Science Solution (Antimicrobial Agent) Clinical Trial Eligibility Overview. Trial Name: NCT04906642 — N/A
Surgical Site Infection Research Study Groups: Standard of Care, Standard of Care plus Next Science
Surgical Site Infection Clinical Trial 2023: Next Science Solution Highlights & Side Effects. Trial Name: NCT04906642 — N/A
Next Science Solution (Antimicrobial Agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04906642 — N/A
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top